FDA Investigator Suzanne M Muchene
Suzanne M Muchene has inspections in 1 countries as of 07 Jun 2021. Suzanne M Muchene has collaborated with a combined 1316 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
07 Jun 2021
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alicia M Mozzachio,
Brooke K Higgins,
Brooke K Seeman,
Carole L Jones,
Chiang Syin, PhD,
Chryste D Best,
Colleen F Hoyt,
Diane T Bargo,
Diane T O'brien,
Dianne H Milazzo,
Donald L Lech,
Douglas A Campbell,
Edward P Potter,
Edwin Melendez,
Emest F Bizjak,
Gale L Glinecki,
George Pyramides,
Gerald B Seaborn, Jr,
Holly S Simms,
Jaison J Eapen,
James L Dunnie, Jr,
James M Simpson,
James W Leonette,
Jean Blackston Hill,
John Dan,
Jonathan W Chapman,
Jose R Hernandez,
Keith M Reilly,
Kenneth M Gordon,
Kenneth Nieves,
Latoya Oliver Powell,
Latoya S Oliver Powell,
Laurissa S Flowers,
LCDR Anastasia Mpiliafas Brown,
Liatte Kreuger, PharmD,
Lori A Holmquist,
Lori A Holquist,
Lori S Lawless,
Lynette P Salisbury,
Marcellinus D Dordunoo,
Matthew M Henciak,
Melissa J Garcia,
Merideth K Rose,
Nebil A Oumer,
Nerizza B Guerin,
Patricia A Morrow,
Patrick C Klotzbuecher,
Pratik S Upadhyay, DDC,
Qiang Gui,
Qin Xu,
Rachel C Harrington,
Rebecca Rodriguez,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Stacey A Priest,
Stephanie I Shapley,
Stephanie L Shapley,
Steven P Donald,
Suzanne M Healy,
Tajah L Blackburn,
Tiffani D Wilson,
Vesna V Stanoyevitch,
Vipulchandr N Dholakia,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
William J Leonard,
Xiandong Meng,
Yan Qin,
Yvonne C Mcknight,
Zhongren Wu
Suzanne M Muchene's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more